Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphomaPaolo Strati, Jason R. Westin, Bryan Do et al.|Blood Advances|2020Cited by 195
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapySushanth Gouni, Paolo Strati, Allison Rosenthal et al.|Blood Advances|2022Cited by 37
A Multi-Center Retrospective Study of Polatuzumab for Patients with Large B-Cell Lymphoma Relapsed after Standard of Care CAR T-Cell TherapySushanth Gouni, Paolo Strati, Allison Rosenthal et al.|Blood|2021Cited by 1
An Updated Multi-Center Retrospective Study of Polatuzumab for Patients with Large B-Cell Lymphoma Relapsed after Standard of Care CAR T-Cell TherapyPaolo Strati, Sattva S. Neelapu, Yi Lin et al.|Transplantation and Cellular Therapy|2022Cited by 0